Skip to main content

11 Result(s)

within H. J. Spaar Remove this filter

and

  1. No Access

    Article

    Primary malignant rhabdoid tumours of the central nervous system: An immunohistochemical and ultrastructural study

    Three cases of primary rhabdoid tumour of the CNS (RT-CNS) are presented. In case 1 a hemispheric tumour developed in a 10.5 months old girl, who survived for 6 months after incomplete resection, radio- and po...

    M. Bergmann, H. J. Spaar, G. Ebhard, T. Masini, G. Edel… in Acta Neurochirurgica (1997)

  2. No Access

    Article

    Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood — follow up after 9 years

    A frequent change of drug combinations may circumvent drug resistance in the treatment of patients with acute lymphoblastic leukaemia (ALL). In study COALL 85/89 201 children with high-risk ALL were randomized...

    G. E. Janka-Schaub, D. Harms, U. Goebel, U. Graubner… in European Journal of Pediatrics (1996)

  3. No Access

    Article

    Abstracts

    J. M. Derlon MD, M. C. Petit-taboué MD, F. Dauphin PhD… in Journal of Neuro-Oncology (1994)

  4. No Access

    Article

    Wilms' tumor — treatment and prognosis of 373 children

    Between June 1980 and June 1988, 373 patients with Wilms' tumors were diagnosed and treated (34.5%, stage I; 34.5%, stage II; 14.8%, stage III; 10.7%, stage IV; and 5.4%, stage V). In all, 11% of the patients ...

    R. Wammack, M. Fisch, H. J. Spaar, J. Kühl, P. Gutjahr… in World Journal of Urology (1992)

  5. No Access

    Chapter and Conference Paper

    Phase I/II Trial with Low-Dose Interleukin-2 and Interferon-Gamma in Children with High-Risk Leukemia and Non-Hodgkin’s Lymphoma After Autologous Bone Marrow Transplantation

    About 40% of patients suffering from early (first remission duration under 18 months) or recurrent relapses of acute lymphoblastic leukemia (ALL) remain relapse-free after being treated with allogeneic bone ma...

    E. Baumgarten, H. Schmid, U. Pohl, J. Kühl… in Cytokines in Hemopoiesis, Oncology, and AI… (1992)

  6. No Access

    Chapter and Conference Paper

    Bone Marrow Blast Count at Day 28 as the Single Most Important Prognostic Factor in Childhood Acute Lymphoblastic Leukemia

    Intensification of therapy and risk-adapted treatment have increased the cure rates for childhood acute lymphocytic leukemia (ALL) to 60%–70% [1–5]. Among the prognostic parameters the initial white blood coun...

    G. E. Janka-Schaub, H. Stuehrk, B. Kortuem, U. Graubner, R. J. Haas… in Acute Leukemias (1992)

  7. No Access

    Chapter and Conference Paper

    Improved Prognosis for Childhood Acute Lymphocytic Leukemia with Very High White Blood Cell Count (> 100/nl) with Rotation of Non-Cross-Resistant Drug Combinations

    Among several initial prognostic factors in acute lymphoblastic leukemia (ALL), i.e., age, hepatosplenomegaly, immunologic subtype, and chromosomal abnormalities [1–4], an elevated white blood count (WBC) at d...

    G. E. Janka-Schaub, U. Goebel, U. Graubner, R. J. Haas, H. Juergens… in Acute Leukemias II (1990)

  8. No Access

    Article

    Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83)

    In January 1983, the German Society of Pediatric Oncology started a cooperative trial (MAKEI 83) for non-testicular germ-cell tumors. The pilot phase closed in December 1985. The treatment regimen was stratifi...

    U. Göbel, G. Calaminus, R. J. Haas, H. Jürgens… in Cancer Chemotherapy and Pharmacology (1989)

  9. No Access

    Chapter and Conference Paper

    New Aspects in the Treatment of Childhood Rhabdomyosarcoma: Results of the German Cooperative Soft-Tissue Sarcoma Study (CWS-81)

    Prior to the introduction of chemotherapy only 10–20% of children suffering from rhabdomyosarcomas (RMS) were successfully treated by surgery alone [1–4]. The introduction of combined multi-agent cytostatic th...

    J. Treuner, J. Kühl, J. Beck, J. Ritter, H. J. Spaar… in Pediatric Surgical Oncology (1989)

  10. No Access

    Chapter and Conference Paper

    Aggressive Combination Chemotherapy of Bone Marrow Relapse in Childhood Acute Lymphoblastic Leukemia Containing Aclacinomycin-A: A Multicentric Trial

    An intensive 7-day combination chemotherapy protocol was designed to reinduce children with early bone marrow relapse of acute lymphoblastic leukemia (less than 6 months after the end of or during preceding tr...

    R. Fengler, S. Buchmann, H. Riehm, F. Berthold, R. Dopfer, N. Graf… in Acute Leukemias (1987)

  11. No Access

    Article

    Intermediate-dose methotrexate in the treatment of childhood acute lymphocytic leukaemia: lack of benefit during maintenance therapy following intensive induction therapy

    One hundred and fifty-one children with acute lymphocytic leukaemia (ALL) received multiple agent induction chemotherapy followed by intensive phase treatment. One hundred and thirty-seven patients were random...

    G. E. Janka-Schaub, K. Winkler, H. Jürgens, U. Goebel… in European Journal of Pediatrics (1986)